The Anomali Platform Advances Intelligence-Driven Detection and Response Capabilities and Prevents Business Disruptions While Optimizing Security Expense
15.9.2022 02:46:00 EEST | Business Wire | Press release
Anomali, the leader in intelligence-driven cybersecurity solutions, announced the general availability today of its quarterly platform update to meet the expanding needs of its customers and partners. This release introduces new capabilities to enhance Anomali’s threat intelligence and extended detection and response (XDR) use cases that enable enterprise organizations to stay one step ahead of adversaries and prevent business disruptions while optimizing security expenses.
“Anomali’s August release offers new capabilities and enhancements for security operations teams struggling to identify not only who’s targeting them, but how and why they are being targeted,” said Mark Alba, Chief Product Officer at Anomali.
Key highlights of this release include:
Creating Extended Visibility with Anomali Attack Pattern Detection and MITRE ATT&CK®: In 2021, Anomali joined MITRE Engenuity’s Center for Threat-Informed Defense to collaborate on the Attack Flow Project to better understand adversary behavior and improve defensive capabilities. This partnership culminated with the public release of the project in March 2022.
Since then, Anomali has been working to incorporate attack flows into The Anomali Platform. This release moves the platform toward an Attack Flow Library for Anomali ThreatStream that will provide an access point for new Attack Flows that sequence cyberattack techniques. This capability will provide a new context around adversary behavior and help security teams expertly profile the adversary. It will also enable them better to protect the organization in advance of an attack, detect an attack in real-time, and respond post-attack.
Furthermore, this predictive visual mapping will be leveraged by CISOs and security professionals to align attacks with potential holes in their security posture to get in front of the threat.
“ESG research found that 97% of security professionals believe that MITRE ATT&CK is important to their organization’s security operations strategy,” said Jon Oltsik, Senior Principal Analyst and Fellow, ESG Research. “Anomali’s commitment to integrating the MITRE ATT&CK Framework into its solutions and participating in the MITRE Engenuity Center for Threat Informed Defense can help security teams adopt the framework and better understand cyber-adversaries.”
Routine Workflow Automation: Given macro-economic conditions, customers are looking for capabilities that make their existing investments more impactful. We’ve introduced a new extensible framework to support the automation of routine tasks throughout the platform. This release's first implementation is available to automate enrichments in the investigations workbench. A drag-and-drop process for configuring a multi-stage enrichment task can easily be set and run when conditions require it, saving analysts time performing repetitive tasks.
Additional enhancements with this platform release include:
- Support for MITRE ATT&CK Mobile & ICS: Intelligence aggregation, contextualization, and analysis for Mobile and ICS attack surfaces to strengthen overall security posture.
- MITRE ATT&CK Enterprise v11 in Anomali Lens
- Scheduled Retrospective Search: Helps the SOC automate the correlation of historical events with newly available intelligence to produce reports and gain insight into threat actors, TTPs, or other adversary behavior. This new capability enables CISOs to detect real-time threats in their local IT environment.
Anomali will be exhibiting at BlackHat on August 10 & 11, Booth #3034. Stop by to chat with the team and learn more about our intelligence-driven solutions.
About Anomali
Anomali is the leader in intelligence-driven extended detection and response (XDR) cybersecurity solutions. Anchored by big data management (the “X”) and refined by artificial intelligence, The Anomali Platform, an XDR solution, delivers unique proprietary capabilities that correlate the largest repository of global intelligence with telemetry from customer-deployed security solutions. This combination empowers security operations teams to accurately detect threats, optimize response, achieve resiliency, and ultimately stop attackers and breaches. Our SaaS-based solutions easily integrate into existing security tech stacks through native-cloud, multi-cloud, on-premises, and hybrid deployments. Founded in 2013, Anomali serves global B2B enterprise businesses, large public sector organizations, ISACs, ISAOs, service providers, and Global 1000 customers to help safeguard the world’s critical infrastructure, companies, and people. Leading venture firms, including Google Ventures, General Catalyst, and IVP, back Anomali. Learn more at www.anomali.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005789/en/
Contact information
Karen Buffo
news@anomali.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer13.7.2026 13:00:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of approximately $85 million in upfront gross proceeds, before the deduction of private placement expenses, and up to an additional $255 million upon the full exercise of purchase warrants. The financing was led by Commodore Capital, with participation from RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals. The net proceeds of this financing are expected to support Agenus’ strategic prioritization of botensilimab and balstilimab (BOT+BAL) for the neoadjuvant treatment of microsatellite-stable (MSS) colon cancer, including advancement of ROBBIN1, the Company’s planned registrational Phase 3 neoadjuvant trial in microsatellite-stable (MSS) colon cancer. High-risk Stage II and Stage III MSS colon cancer affect an estimated 38,000 patients annually in the US and more than 200,000 patients worldwide,2 representing a
Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation13.7.2026 12:48:00 EEST | Press release
The Zayed Sustainability Prize, the UAE’s pioneering award for innovative solutions to global challenges, has officially closed submissions for its 2027 awards cycle, receiving an unprecedented 10,233 entries from 177 countries across its six categories of Health, Food, Energy, Water, Climate Action and Global High Schools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713519403/en/ Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation (Photo: AETOSWire) Now in its 18th year, the Prize continues to attract a diverse and growing pool of small and medium-sized enterprises, nonprofit organisations and high schools developing solutions that improve lives, particularly in vulnerable and underserved communities. This year’s submissions point to a growing emphasis on resilience, adaptability and systems-level impact. Across regions, applicants are addressing complex global challenges through practi
Ant Group Open-Sources SingGuard-NSFA to Establish New Security Paradigms for Autonomous AI Agents13.7.2026 12:01:00 EEST | Press release
Ant Group’s AI Security Lab today announced the open-source release of SingGuard-NSFA, a specialized security guardrail framework designed specifically for autonomous AI agents. The framework secures agentic AI systems against operational threats like prompt injection, addressing critical vulnerabilities as AI transitions from passive content generation to active, autonomous execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712722454/en/ As AI agents rapidly move from research labs to business scenarios, the security landscape has fundamentally shifted. The explosive global adoption of open-source agent frameworks like OpenClaw, celebrated for their "one-click deployment" and "full-stack autonomy", has simultaneously exposed significant operational risks, including permission escalation and prompt injection. Industry frameworks, including the OWASP (Open Web Application Security Project) Top 10 for Agentic Applica
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types13.7.2026 11:00:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, investigational monoclonal antibody for patients with von Willebrand disease (VWD). The data are being shared in an oral presentation today at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH 2026 Congress) in Paris. Latarcibart modulates Protein S to improve hemostasis, potentially enhancing the body’s ability to prevent or reduce the frequency of bleeding episodes. Latarcibart is in pivotal Phase 3 development for patients with VWD, the most common inherited bleeding disorder. If approved, latarcibart has the potential to be the first, once monthly subcutaneous prophylactic therapy for patients with VWD, offering an important alternative to the frequent intravenous infusions of replacement factor concentrates commonly used in the prophylactic setting today. Gi
Europe’s Demand for Tech Services Accelerates in Q2, As Spending on AI and Managed Services Rises: ISG Index™13.7.2026 11:00:00 EEST | Press release
Demand for technology services in Europe continued to accelerate in the second quarter, as the region increasingly turns to managed services to reduce costs and cloud services to meet AI objectives, according to the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows second-quarter ACV for the combined market (both managed services and cloud-based as-a-service) soared 46 percent—its largest growth in eight years—to US $13.0 billion. The latest quarter adds to a string of three straight quarters in which growth has averaged 33 percent. “Europe has become the fastest-growing region for technology services, fueled not only by an increasing demand for AI, but for managed services, which acts as a cost-savings lever to help fund AI ambitions and continued digital
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
